Mednet Logo
HomeGeriatric MedicineQuestion

In older adults with mild cognitive impairment, do you ever prescribe cholinesterase inhibitors and/or memantine?

3
7 Answers
Mednet Member
Mednet Member
Geriatric Medicine · Wake Forest University School of Medicine

This is a great question, and of course, "do you ever" will get you in trouble every time!

Let me start by saying that, in general, I do not prescribe these drugs for MCI. Cholinesterase inhibitors are clearly indicated for the mild-moderate stage of some kinds of dementia (some people would include...

Register or Sign In to see full answer

Mednet Member
Mednet Member
Geriatric Medicine · UCLA Medical Center

Cognitive benefits of anticholinesterase inhibitors are small and not clinically meaningful in the short term in which the clinical trials were conducted. Observational studies in patients with dementia do show benefits in both cognition and behaviors and the ability to live independently in the lon...

Register or Sign In to see full answer

Mednet Member
Mednet Member
Neurology · Inova Health System

In my anecdotal experience, my MCI-Lewy bodies patients can have a strikingly positive response to cholinesterase inhibitors.

Register or Sign In to see full answer

Mednet Member
Mednet Member
Psychiatry · Shifa Health

In my experience, the cognitive enhancers work best when anxiety, regardless of the working diagnosis, MCI, AD, is present, and regardless of the patient’s insight. Aricept and Namenda seem to flatten, at least for a time, the slope of the worsening impairment. These meds improve anxiety associated ...

Register or Sign In to see full answer

Mednet Member
Mednet Member
Psychiatry · Thapar Renu K Office

I have used cognitive-enhancing drugs for a long time.

In my experience, some subset of patients do very well, and the benefit lasts for years in keeping them at home and more independent.

Generally, these patients start medication soon after early diagnosis.

I have distinctly noticed behavioral imp...

Register or Sign In to see full answer

Mednet Member
Mednet Member
General Internal Medicine · Wentworth-Douglass Hospital

Many have noted unfavorable risk-benefit ratios and limited, if any response to these drugs. This obviously contradicts FDA approvals and advertised utility.

Some isolated studies found CNS-penetrating leukotriene inhibitors to be effective in long-term (but not acute) treatment for this and mild to...

Register or Sign In to see full answer

Mednet Member
Mednet Member
General Internal Medicine · Wentworth-Douglass Hospital

The responses are revealing some interesting patterns, in part predicted by the published data. Some have had significant or marked improvement in Lewy body dementia and other dementias by some, others have found no response in both types of loss of function. A marked improvement in anxiety and corr...

Register or Sign In to see full answer